Figure 1.

Percentage of etanercept- and placebo-treated patients demonstrating ACR20, ACR50, and ACR70 responses at 24 weeks. ACR, American College of Rheumatology. *P < 0.0001. ^†P = 0.009. Reproduced with permission from John Wiley & Sons, Inc. [27]. ^© 2001 American College of Rheumatology